TABLE 2.
Overall baseline characteristics of pooled groups of colchicine and placebo patients.
| Colchicine (n = 1141) | Placebo (n = 1133) | p | |
| Age, yrs | 63.99 ± 11.35 (734) | 64.73 ± 9.93 (711) | 0.19 |
| Male | 690/963 (71.7%) | 675/943 (71.6%) | 0.97 |
| Hypertension | 603/963 (62.6%) | 601/943 (63.7%) | 0.61 |
| Diabetes mellitus | 307/963 (31.9%) | 300/943 (31.8%) | 0.98 |
| Smoking | 251/794 (31.6%) | 267/776 (34.4%) | 0.24 |
| CAD | 171/523 (32.7%) | 181/511 (35.4%) | 0.36 |
| Prior MI | 99/381 (26.0%) | 96/362 (26.5%) | 0.87 |
| COPD | 51/448 (11.4%) | 57/439 (13.0%) | 0.47 |
| CHF | 75/581 (12.9%) | 79/572 (13.8%) | 0.65 |
Values are n/N (%) or mean ± SD. CAD, coronary artery disease, CHF, congestive heart failure, COPD, chronic obstructive pulmonary disease, MI, myocardial infarction. The descriptive statistics in this table are based on available data in the included studies, as some studies did not reported all patients’ characteristics.